The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Meloxicam Drug-Global Market Insights and Sales Trends 2025

Meloxicam Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808755

No of Pages : 112

Ask Your Query
Synopsis
Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 
The global Meloxicam Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Meloxicam Drug in various end use industries. The expanding demands from the Osteoarthritis in Adults (OA), Rheumatoid Arthritis in Adults (RA) and Pediatric Patients,, are propelling Meloxicam Drug market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Meloxicam Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Meloxicam Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Meloxicam Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Meloxicam Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Meloxicam Drug covered in this report include Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals and Strides Pharma, etc.
The global Meloxicam Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Global Meloxicam Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Meloxicam Drug market, Segment by Type:
Tablet
Capsule
Global Meloxicam Drug market, by Application
Osteoarthritis in Adults (OA)
Rheumatoid Arthritis in Adults (RA)
Pediatric Patients
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Meloxicam Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Meloxicam Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Meloxicam Drug Market Overview
1.1 Meloxicam Drug Product Overview
1.2 Meloxicam Drug Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.3 Global Meloxicam Drug Market Size by Type
1.3.1 Global Meloxicam Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Meloxicam Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Meloxicam Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Meloxicam Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Meloxicam Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Meloxicam Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Meloxicam Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Meloxicam Drug Sales Breakdown by Type (2018-2023)
2 Global Meloxicam Drug Market Competition by Company
2.1 Global Top Players by Meloxicam Drug Sales (2018-2023)
2.2 Global Top Players by Meloxicam Drug Revenue (2018-2023)
2.3 Global Top Players by Meloxicam Drug Price (2018-2023)
2.4 Global Top Manufacturers Meloxicam Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Meloxicam Drug Market Competitive Situation and Trends
2.5.1 Meloxicam Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Meloxicam Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Meloxicam Drug Market
2.8 Key Manufacturers Meloxicam Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Meloxicam Drug Status and Outlook by Region
3.1 Global Meloxicam Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Meloxicam Drug Historic Market Size by Region
3.2.1 Global Meloxicam Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Meloxicam Drug Sales in Value by Region (2018-2023)
3.2.3 Global Meloxicam Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Meloxicam Drug Forecasted Market Size by Region
3.3.1 Global Meloxicam Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Meloxicam Drug Sales in Value by Region (2024-2029)
3.3.3 Global Meloxicam Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Meloxicam Drug by Application
4.1 Meloxicam Drug Market Segment by Application
4.1.1 Osteoarthritis in Adults (OA)
4.1.2 Rheumatoid Arthritis in Adults (RA)
4.1.3 Pediatric Patients
4.2 Global Meloxicam Drug Market Size by Application
4.2.1 Global Meloxicam Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Meloxicam Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Meloxicam Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Meloxicam Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Meloxicam Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Meloxicam Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Meloxicam Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Meloxicam Drug Sales Breakdown by Application (2018-2023)
5 North America Meloxicam Drug by Country
5.1 North America Meloxicam Drug Historic Market Size by Country
5.1.1 North America Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Meloxicam Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Meloxicam Drug Sales in Value by Country (2018-2023)
5.2 North America Meloxicam Drug Forecasted Market Size by Country
5.2.1 North America Meloxicam Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Meloxicam Drug Sales in Value by Country (2024-2029)
6 Europe Meloxicam Drug by Country
6.1 Europe Meloxicam Drug Historic Market Size by Country
6.1.1 Europe Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Meloxicam Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Meloxicam Drug Sales in Value by Country (2018-2023)
6.2 Europe Meloxicam Drug Forecasted Market Size by Country
6.2.1 Europe Meloxicam Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Meloxicam Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Meloxicam Drug by Region
7.1 Asia-Pacific Meloxicam Drug Historic Market Size by Region
7.1.1 Asia-Pacific Meloxicam Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Meloxicam Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Meloxicam Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Meloxicam Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Meloxicam Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Meloxicam Drug Sales in Value by Region (2024-2029)
8 Latin America Meloxicam Drug by Country
8.1 Latin America Meloxicam Drug Historic Market Size by Country
8.1.1 Latin America Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Meloxicam Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Meloxicam Drug Sales in Value by Country (2018-2023)
8.2 Latin America Meloxicam Drug Forecasted Market Size by Country
8.2.1 Latin America Meloxicam Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Meloxicam Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Meloxicam Drug by Country
9.1 Middle East and Africa Meloxicam Drug Historic Market Size by Country
9.1.1 Middle East and Africa Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Meloxicam Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Meloxicam Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Meloxicam Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Meloxicam Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Meloxicam Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boehringer-Ingelheim
10.1.1 Boehringer-Ingelheim Company Information
10.1.2 Boehringer-Ingelheim Introduction and Business Overview
10.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boehringer-Ingelheim Meloxicam Drug Products Offered
10.1.5 Boehringer-Ingelheim Recent Development
10.2 TerSera Therapeutics
10.2.1 TerSera Therapeutics Company Information
10.2.2 TerSera Therapeutics Introduction and Business Overview
10.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 TerSera Therapeutics Meloxicam Drug Products Offered
10.2.5 TerSera Therapeutics Recent Development
10.3 Iroko Pharmaceuticals
10.3.1 Iroko Pharmaceuticals Company Information
10.3.2 Iroko Pharmaceuticals Introduction and Business Overview
10.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Iroko Pharmaceuticals Meloxicam Drug Products Offered
10.3.5 Iroko Pharmaceuticals Recent Development
10.4 Apotex
10.4.1 Apotex Company Information
10.4.2 Apotex Introduction and Business Overview
10.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Apotex Meloxicam Drug Products Offered
10.4.5 Apotex Recent Development
10.5 Yung Shin Pharmaceutical
10.5.1 Yung Shin Pharmaceutical Company Information
10.5.2 Yung Shin Pharmaceutical Introduction and Business Overview
10.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Yung Shin Pharmaceutical Meloxicam Drug Products Offered
10.5.5 Yung Shin Pharmaceutical Recent Development
10.6 Breckenridge Pharmaceutical
10.6.1 Breckenridge Pharmaceutical Company Information
10.6.2 Breckenridge Pharmaceutical Introduction and Business Overview
10.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Breckenridge Pharmaceutical Meloxicam Drug Products Offered
10.6.5 Breckenridge Pharmaceutical Recent Development
10.7 Zydus Pharmaceuticals
10.7.1 Zydus Pharmaceuticals Company Information
10.7.2 Zydus Pharmaceuticals Introduction and Business Overview
10.7.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zydus Pharmaceuticals Meloxicam Drug Products Offered
10.7.5 Zydus Pharmaceuticals Recent Development
10.8 Unichem Pharmaceuticals
10.8.1 Unichem Pharmaceuticals Company Information
10.8.2 Unichem Pharmaceuticals Introduction and Business Overview
10.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Unichem Pharmaceuticals Meloxicam Drug Products Offered
10.8.5 Unichem Pharmaceuticals Recent Development
10.9 Strides Pharma
10.9.1 Strides Pharma Company Information
10.9.2 Strides Pharma Introduction and Business Overview
10.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Strides Pharma Meloxicam Drug Products Offered
10.9.5 Strides Pharma Recent Development
10.10 Cipla
10.10.1 Cipla Company Information
10.10.2 Cipla Introduction and Business Overview
10.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cipla Meloxicam Drug Products Offered
10.10.5 Cipla Recent Development
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Company Information
10.11.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dr. Reddy's Laboratories Meloxicam Drug Products Offered
10.11.5 Dr. Reddy's Laboratories Recent Development
10.12 Glenmark Pharmaceuticals
10.12.1 Glenmark Pharmaceuticals Company Information
10.12.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Glenmark Pharmaceuticals Meloxicam Drug Products Offered
10.12.5 Glenmark Pharmaceuticals Recent Development
10.13 Teva
10.13.1 Teva Company Information
10.13.2 Teva Introduction and Business Overview
10.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Teva Meloxicam Drug Products Offered
10.13.5 Teva Recent Development
10.14 PuraCap Pharmaceutical
10.14.1 PuraCap Pharmaceutical Company Information
10.14.2 PuraCap Pharmaceutical Introduction and Business Overview
10.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 PuraCap Pharmaceutical Meloxicam Drug Products Offered
10.14.5 PuraCap Pharmaceutical Recent Development
10.15 TARO
10.15.1 TARO Company Information
10.15.2 TARO Introduction and Business Overview
10.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 TARO Meloxicam Drug Products Offered
10.15.5 TARO Recent Development
10.16 Lupin Pharmaceuticals
10.16.1 Lupin Pharmaceuticals Company Information
10.16.2 Lupin Pharmaceuticals Introduction and Business Overview
10.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Lupin Pharmaceuticals Meloxicam Drug Products Offered
10.16.5 Lupin Pharmaceuticals Recent Development
10.17 Aurobindo Pharma
10.17.1 Aurobindo Pharma Company Information
10.17.2 Aurobindo Pharma Introduction and Business Overview
10.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Aurobindo Pharma Meloxicam Drug Products Offered
10.17.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Meloxicam Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Meloxicam Drug Industrial Chain Analysis
11.4 Meloxicam Drug Market Dynamics
11.4.1 Meloxicam Drug Industry Trends
11.4.2 Meloxicam Drug Market Drivers
11.4.3 Meloxicam Drug Market Challenges
11.4.4 Meloxicam Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Meloxicam Drug Distributors
12.3 Meloxicam Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock